Back
Supernus Pharmaceuticals Stock Price Chart
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
47
SUPN
Supernus Pharmaceuticals
Last Price:
$32.32
Seasonality Move:
10.72%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.-
The current trend is relatively stagnant and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.08 | Buy |
| 20-day SMA: | 32.18 | Buy |
| 50-day SMA: | 32.02 | Buy |
| 200-day SMA: | 34.22 | Sell |
| 8-day EMA: | 32.15 | Buy |
| 20-day EMA: | 32.17 | Buy |
| 50-day EMA: | 32.41 | Sell |
| 200-day EMA: | 33.14 | Sell |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 51.26 | Buy |
| Chaikin Money Flow: | 231918 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.7 - 32.8) | Buy |
| Bollinger Bands (100): | (30.89 - 36.87) | Sell |
Supernus Pharmaceuticals Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 32.30 while SUPN 8-day simple moving average is 32.08, which is a Buy signal.
-
The stock price of SUPN is 32.30 while Supernus Pharmaceuticals 20-day SMA is 32.18, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day simple moving average is 32.02 while SUPN share price is 32.30, making it a Buy technically.
-
SUPN stock price is 32.30 and Supernus Pharmaceuticals 200-day simple moving average is 34.22, creating a Sell signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
47
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a SellThe current Supernus Pharmaceuticals [SUPN] share price is $32.30. The Score for SUPN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.8B
Price in USD:
32.30
Share Volume:
368K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
40.28
52-Week Low:
25.53
Sell
47
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?The Supernus Pharmaceuticals stock price is 32.30 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 32.30 while SUPN 8-day exponential moving average is 32.15, which is a Buy signal.
-
The stock price of SUPN is 32.30 while Supernus Pharmaceuticals 20-day EMA is 32.17, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day exponential moving average is 32.41 while SUPN share price is 32.30, making it a Sell technically.
-
SUPN stock price is 32.30 and Supernus Pharmaceuticals 200-day simple moving average is 33.14, creating a Sell signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.86 per share, and an increase next year of $0.48 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Supernus Pharmaceuticals is a Sell
-
Supernus Pharmaceuticals Relative Strength Index (RSI) is 51.26, which suggest Supernus Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Supernus Pharmaceuticals is (31.7 - 32.8), which suggest Supernus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Supernus Pharmaceuticals is (30.89 - 36.87), which suggest Supernus Pharmaceuticals is a Sell
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.